What does CUSIP 036752103 represent in this 13F holders report?

CUSIP 036752103 is the security identifier for ELV - Elevance Health, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ELV - Elevance Health, Inc. - Common Stock in Q1 2018?

914 institutional investors reported ELV - Elevance Health, Inc. - Common Stock for Q1 2018. Use the holders table for investor-level position and value details.

Elevance Health, Inc. - Common Stock (ELV)

CUSIP: 036752103

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock
Shares outstanding: 225,970,109
Total 13F shares: 226,170,388
Share change: +695,423
Total reported value: $49,620,249,094
Put/Call ratio: 70%
Price per share: $219.70
Number of holders: 914
Value change: +$136,418,805
Number of buys: 362
Number of sells: 463

Quarterly Holders Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 036752103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	9.7%	22,000,430	$4,950,317,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	7.9%	17,803,582	$4,005,985,000	—	31 Dec 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	7.5%	16,869,167	$3,795,730,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	4.8%	10,936,009	$2,460,736,000	—	31 Dec 2017	13F
FMR LLC	13F	Company	4.2%	9,388,356	$2,112,475,000	—	31 Dec 2017	13F
BAILLIE GIFFORD & CO	13F	Company	2.2%	4,879,122	$1,097,852,000	—	31 Dec 2017	13F
Invesco Ltd.	13F	Company	1.7%	3,945,270	$887,726,000	—	31 Dec 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.7%	3,906,705	$879,048,000	—	31 Dec 2017	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	1.6%	3,722,268	$837,548,000	—	31 Dec 2017	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	1.5%	3,455,124	$777,437,000	—	31 Dec 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.5%	3,384,725	$761,598,000	—	31 Dec 2017	13F
Boston Partners	13F	Company	1.5%	3,342,806	$752,165,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	1.4%	3,255,541	$732,529,000	—	31 Dec 2017	13F
First Eagle Investment Management, LLC	13F	Company	1.4%	3,143,500	$707,319,000	—	31 Dec 2017	13F
GLENVIEW CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	3,057,497	$687,967,000	—	31 Dec 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	3,006,290	$676,502,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	2,864,024	$643,146,000	—	31 Dec 2017	13F
NORGES BANK	13F	Company	1.1%	2,550,328	$573,849,000	—	31 Dec 2017	13F
VIKING GLOBAL INVESTORS LP	13F	Company	1.1%	2,537,576	$570,980,000	—	31 Dec 2017	13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC	13F	Company	1.1%	2,475,627	$557,041,000	—	31 Dec 2017	13F
LSV ASSET MANAGEMENT	13F	Company	1.1%	2,472,099	$556,246,000	—	31 Dec 2017	13F
Orbis Allan Gray Ltd	13F	Company	1.1%	2,432,125	$547,252,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	1.1%	2,377,977	$535,069,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	1%	2,353,207	$529,496,000	—	31 Dec 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	1%	2,328,634	$523,965,000	—	31 Dec 2017	13F
OppenheimerFunds, Inc.	13F	Company	0.96%	2,163,579	$486,826,000	—	31 Dec 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.85%	1,931,170	$434,532,561	—	31 Dec 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.85%	1,916,546	$431,242,000	—	31 Dec 2017	13F
Sanders Capital, LLC	13F	Company	0.83%	1,878,622	$422,709,000	—	31 Dec 2017	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.78%	1,759,756	$395,963,000	—	31 Dec 2017	13F
LYRICAL ASSET MANAGEMENT LP	13F	Company	0.76%	1,724,931	$388,127,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.73%	1,657,199	$372,886,000	—	31 Dec 2017	13F
Allianz Asset Management GmbH	13F	Company	0.7%	1,582,650	$356,112,000	—	31 Dec 2017	13F
APG Asset Management N.V.	13F	Company	0.82%	1,857,010	$347,973,000	—	31 Dec 2017	13F
Legal & General Group Plc	13F	Company	0.67%	1,520,283	$342,109,000	—	31 Dec 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.66%	1,481,727	$333,407,000	—	31 Dec 2017	13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	13F	Company	0.65%	1,466,718	$330,026,000	—	31 Dec 2017	13F
Vulcan Value Partners, LLC	13F	Company	0.59%	1,327,283	$298,652,000	—	31 Dec 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.52%	1,175,345	$264,464,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.51%	1,160,085	$261,031,000	—	31 Dec 2017	13F
EdgePoint Investment Group Inc.	13F	Company	0.51%	1,146,321	$257,934,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	1,092,887	$245,911,000	—	31 Dec 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.47%	1,070,549	$240,906,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.46%	1,033,341	$232,512,000	—	31 Dec 2017	13F
Artisan Partners Limited Partnership	13F	Company	0.44%	1,000,033	$225,017,000	—	31 Dec 2017	13F
Russell Investments Group, Ltd.	13F	Company	0.44%	985,515	$223,656,000	—	31 Dec 2017	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	0.42%	956,507	$215,224,000	—	31 Dec 2017	13F
YACKTMAN ASSET MANAGEMENT LP	13F	Company	0.37%	835,712	$188,044,000	—	31 Dec 2017	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.36%	823,000	$185,183,000	—	31 Dec 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.36%	816,724	$183,771,000	—	31 Dec 2017	13F

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2018

As of 31 Mar 2018, Elevance Health, Inc. - Common Stock (ELV) was held by 914 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 226,170,388 shares. The largest 10 holders included BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, BAILLIE GIFFORD & CO, Viking Global Investors LP, Invesco Ltd., WELLINGTON MANAGEMENT GROUP LLP, and NORTHERN TRUST CORP. This page lists 915 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

904

Q1 2018 holders

914

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.